UK Earnings, Trading Statements Calendar | |
Thursday, October 22 | |
Inchcape | Q3 Interim Management Statement |
Ladbrokes | Q3 Interim Management Statement |
Lombard Risk Management | Half Year Results |
Stobart | Half Year Results |
Rathbone Brothers | Q3 Interim Management Statement |
Travis Perkins | Q3 Interim Management Statement |
GKN | Q3 Interim Management Statement |
Anglo American | Q3 Production Report |
Britvic | Trading Statement |
Debenhams | Full Year Results |
Foxtons | Trading Statement |
Phoenix Group | Q3 Interim Management Statement |
RELX | Trading Statement |
SEGRO | Trading Statement |
London Stock Exchange Group | Q3 Interim Management Statement |
Polyus Gold International | Trading Statement |
Mothercare | Trading Statement |
Friday, October 23 | |
William Hill | Q3 Interim Management Statement |
Shire | Q3 Results |
Dechra Pharmaceuticals | AGM Trading Statement |
Monday, October 26 | |
WPP | Q3 Trading Statement |
Avacta Group | Full Year Group |
Tuesday, October 27 | |
BP | Q3 Results |
Utilitywise | Full Year Results |
St James's Place | Q3 Interim Management Statement |
Carpetright | Trading Statement |
Shoe Zone | Trading Statement |
Bloomsbury Publishing | Half Year Results |
International Personal Finance | Q3 Interim Management Statement |
Wednesday, October 28 | |
British American Tobacco | Q3 Interim Management Statement |
Standard Life | Q3 Interim Management Statement |
Next | Q3 Trading Statement |
Antofagasta | Q3 Production Report |
GlaxoSmithKline | Q3 Results |
Lloyds Banking Group | Q3 Interim Management Statement |
Redefine International | Full Year Results |
Shanks Group | Trading Statement |
JZ Capital Partners | Half Year Results |
Braemar Shipping | Half Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. |
Fate of most remaining Zantac lawsuits weighed by Delaware judge
Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read more